Cell encapsulation has been broadly investigated as a technology which provides immunoprotection for transplanted endocrine cells. This paper describes a novel technique utilizing a commercially available thermo-molded polypropylene mesh for the mass production of alginate hydrogel microcapsules containing insulin-secreting cells. The encapsulated cells maintain high viability and preserve their ability to proliferate and secrete insulin in a glucoseresponsive manner. We also identify important material properties of the mesh such as surface wettability and pore structures that enable successful formation and retrieval of microcapsules.
Introduction
Cell encapsulation allows for the transplantation of non-autologous cells without the use of immunosuppressive drugs which have potentially severe side-effects [1] [2] [3] [4] . Transplanted living cells are protected from the host immune system because they are encapsulated in a semipermeable hydrogel membrane which allows the diffusion of nutrients and cellular metabolic products while excluding antibodies and immune cells [5] . This technique has potential applications as therapies for many diseases such as diabetes, hormone deficiencies or hepatic failures [4] .
Encapsulated islets have been explored as a technology which allows transplantation of allogenic or xenogeneic insulin-secreting cells into diabetic hosts [6] [7] [8] [9] [10] [11] . Droplet generator system is the most commonly used method in the generation of microcapsules containing islets or other insulin-secreting cells [12] . Typically, a laminar liquid jet is broken into droplets by a harmonically vibrating nozzle combined with an electrostatic dispersion mechanism which prevents droplet aggregation [13] . Currently, droplet generator encapsulation systems are commercially available from several manufacturers such as Inotech and Nisco Engineering AG [websites] . However, the intrinsic one-dimensional dropwise process limits its capacity for production of microcapsules in a large quantity, which is often needed for clinical applications [14, 15] . Attempts have been made to increase production capacity by utilizing parallel multi-nozzle configuration; however, this design significantly increases the size, cost and complexity of the encapsulation system [16] . Multidevice microfluidic platforms may also help to improve the efficiency of microcapsule generation but is still far from cost-effective mass production implementation [17] [18] [19] . Therefore, developing new and convenient methods for mass generation of microcapsules is essential to achieve largescale cell encapsulation.
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Soft-lithography using a PDMS mold has been successfully used to fabricate alginate hydrogel microcapsules in 2D arrays as well as discrete single modules [20] [21] [22] [23] [24] . Many living cells, including bacteria and mammalian cells, have been encapsulated in these hydrogels. However, a potential challenge for this method is the difficulty of releasing the microcapsules from the PDMS mold without damaging the cells. Even though some methods such as mechanical stretching of the mold, swelling the hydrogel capsules in organic solvent [20] or microtransfer molding [23, 25] have been applied to facilitate capsule release, these processes decrease cell viability and capsules yield.
Whitesides et.al. recently demonstrated the production of cell-laden microcapsules using a PDMS membrane with fully penetrating pores to improve the ease of capsule retrieval [26] . However, the accessibility of this method to biologists and tissue engineers is still limited by the necessity of a microfabrication process to generate the PDMS membranes and the difficulty of obtaining membranes with large area .
Here, we describe a novel approach utilizing a commercially available thermo-molded polypropylene mesh for the parallel two-dimensional mass production of alginate hydrogel microcapsules containing insulin-secreting cells. The size of the microcapsule ranges from 400-700 µm with 200um thickness as determined by the pore sizes of the commercially available polymer meshes. This method is a cheap, convenient and fast process to generate cell-laden microcapsules without any specialized equipment or microfabrication process as required in other existing methods. The mechanically robust polymer mesh can also be easily handled and sterilized by autoclaving without affecting its desirable characteristics.
Materials and Methods

Cell culture
The rat insulinoma cell line (INS-1) was a gift from Dr Amedeo Vetere amd Dr Esther O'Sullivan in the Weir group at Joslin Diabetes Center. INS-1 cells at passage of 7-20 were cultured according to a protocol previously described [27] . The cells were cultured in complete medium (CM) composed of RPM1 1640 supplemented with 10 mM HEPES, 10% heat-inactivated fetal calf serum (FCS), 2 mM Lglutamine, 100 U/ml penicillin, 100 rg/ml streptomycin, 1 mM sodium pyruvate, and 50 pM 2-ME. Cultures were incubated at 37 °C in a humidified 95% air-5%
CO2 atmosphere and manipulated under sterile tissue culture hoods. Confluent dish of INS-1 cells was passaged every week at a subculture ratio of 1:3 and fed every 2-3 days. For trypsinization, the adherent cells were exposed to 0.025% trypsin-EDTA solution to yield a cell suspension which was centrifuged at 850 rpm at 4 °C for 3 min. For storage, the cells were suspended in CM containing 10% of dimethyl sulfoxide, and frozen under liquid nitrogen.
Cell encapsulation with thermo-molded polypropylene mesh
Thermo-molded plastic meshes were purchased from McMaster-Carr and Industrial
Netting. The plastic meshes were cut into pieces of 4cmx3cm and placed in a Chex-all® II instant 
Cell viability analysis
The 
Static glucose-stimulated insulin secretion
Five 500 µl aliquots of microcapsules containing INS-1 cells were cultured for a period of 10 days. At the desired time point, the capsules were subjected to a static glucose stimulation study following a procedure slightly modified from a protocol elsewhere [28] . Briefly, the capsule samples were pre-incubated for one hour in Krebs Ringer buffer Hepes (KRBH) (NaCl 137 mM, KCl 4.8 C for storage before insulin assay. Insulin concentrations were determined using Ultrasensive EIA assay kits (ALPCO diagnostics).
Results and Discussion
Selection of template meshes and microcapsule fabrication
We fabricated the alginate hydrogel microcapsules using a process which has been described in details in the experimental section and illustrated in Figure 1 . Briefly, the sterile polymer mesh with an array of uniform pores is brought in gentle contact with the alginate solution We have tested several types of commercial polymer meshes from different suppliers. We found that the material properties and the pore structure of the polymer mesh are important for successfully fabrication of individual alginate capsules. solution is unable to fill the pores. This is similar to observations of trapped air bubbles due to the hydrophobic nature of the PDMS mold [20] and membrane [26] In addition to material property, pore structures such as the steepness of pore sidewall also affect the capsule releasing step (the final step shown in Figure 1 ). Figure 2 shows the polypropylene meshes with two different pore geometries and sidewall steepness. The sidewall of the rectangular pores ( Figure 2C ) is gradually tapered, while the sidewall of the circular pores ( Figure 2D ) is steeper. Cross-linked alginate capsules formed in the pores with tapered sidewalls can be easily displaced by the liquid media during the shaking step. However, the capsules are lodged more tightly in the pores with the steeper sidewalls resulting in lower capsule yield. Overall, thermo-molded b polypropylene meshes from McMaster-Carr (#9265T41) and Industrial Netting (XN-6070, XN-6080) were the best templates for generating individual hydrogel capsules. The XN-6080 mesh was chosen for encapsulation of insulin-secreting cells throughout the paper.
Viability and proliferation of encapsulated cells
b Thermo-molding is an industrially established process used to produce perforated thermoplastic mesh on a large scale. During this process, a heatsoftened thermoplastics film is fed from an extruder onto a rotating cylindrical drum with an outer patterned surface. This film is pulled into conformity with the patterned surface due to the presence of a vacuum on the opposite side forming penetrating pore structures on the plastic film. This resulting mesh is cooled afterwards so that its 3D structure is set prior to its removal from the patterned surface.
We chose INS-1 cells, a cell line derived from x-ray-induced insulinoma in rats, to demonstrate the capability of our technique for the encapsulation of insulin-secreting cells. We fabricated alginate microcapsules containing these cells following the procedure shown in Figure   1 using a suspension of INS-1 cells in 1.5% alginate. Since the presence of cells has an important effect on the rheological properties of alginate, a series of experiments were performed to identify optimal maximum cell-packing density. Figures 3A and B shows cell-laden microcapsules fabricated using poly(propylene) meshes from McMaster (Item #9265T41) and Industrial Netting (Item # XN6080) respectively. The initial cell densities in these microcapsules are in the optimal range of 1.5-2.0×10 6 cells/cm 3 . This range of maximum initial cell density is comparable to that achieved with the commonly used droplet generator [13] .
We also studied the viability and proliferation behavior of the encapsulated cells cultured in vitro for a period of ten days. Figure 3C in Figure 3E and 3F. These viable cells have also proliferated and formed bigger clusters. Next, we used confocal microscopy to study the 3D distribution of cells throughout the entire microcapsule. Figure 4 shows a single capsule at high magnification. Figure 4A and 4B are the projections of multiple images taken at different depth of the capsules (each optical slice is of 2.5um for a total thickness of 200 µm). Figure 4C shows a projected image of the capsules along its diagonal confirming that most cell clusters are alive. These cell clusters are about 20-50um in diameter. They are also uniformly viable and homogeneously distributed in all spatial dimensions of the capsules. 3D video animation of the cell-laden capsule is available in the supplementary data. These results indicate that the nutrient transport through this capsule geometry is sufficient to maintain cell viability and proliferation.
Glucose-stimulated insulin secretion from encapsulated cells
We performed a static glucose challenge to assess the ability of the encapsulated INS-1 cells to maintain their desired glucose-responsive functions. Figure 5 shows the insulin secretion from the cell-laden capsules following ten days of culture in response to two different glucose concentrations. Glucose levels of 2.8 mM and 16.5 mM were used to simulate the physiological basal and hyperglycemic conditions of diabetic patients respectively. At all time points investigated (3 days, 6 days and 10 days) the encapsulated cells were able to maintain the desired glucose-responsive behavior. These cells secreted a higher insulin concentration (1.5 to 3 fold) when subjected to the higher glucose level. The absolute amount of insulin secreted also increases over time confirming that the cells are proliferating in the capsules.
Conclusion
We successfully utilize a commercially available thermo-molded polypropylene mesh to fabricate alginate hydrogel microcapsules containing functional insulin-secreting cells. The mesh [Type text] 
